In particular, the immunopathologic contribution of tumor-like synovial fibroblasts to arthritis relapse following discontinuation of drugs appears highly significant in RA; the stromal origin of these cells may render them resistant to current immune-targeted therapies.
← all excerpts
Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research.
1
—
—